Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
79 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
October 18, 2025
Application History
44 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 7, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 7, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jul 7, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Mar 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 9, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 23, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 23, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jul 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 1, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 27, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 25, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jan 25, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 14, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 12, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Sep 12, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 12, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Apr 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 5, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 5, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 18, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 8, 2022 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
Sep 8, 2022 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
Sep 1, 2022 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
Aug 22, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
Mar 22, 2022 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
Feb 22, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 22, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 2, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 19, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 18, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 18, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 18, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 16, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 16, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 16, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 3, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 8, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD); pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia; none of the aforementioned to include dietary and nutritional supplements or preparations for the treatment of diabetes or related conditions
Classification
International Classes
005